Updated:
Palekana Ltd
Palekana Ltd is the Hong Kong-based family office of British investor Jim Mellon, focusing on biotechnology, real estate, and venture capital.
Palekana Ltd
PALEKANA LTD is a registered investment adviser with the SEC, based in Greater London since 2022.
General information
Firm type
Single Family Office
Year founded
—
AUM
Undisclosed
Location
Region
Asia
Country
Hong Kong
City
Greater London
Corporate office
Hong Kong, Hong Kong
Principals
Jim Mellon
Founder
Sector focus
Frequently asked questions
Who runs investment decisions at Palekana?
Jim Mellon, the founder and principal, directs the firm's investment strategy. He has a public profile as an author and biotech advocate, and his decisions shape the firm's focus on longevity science and Asia-Pacific real estate.
How does Palekana source proprietary deal flow?
Mellon's network from decades in mutual funds and biotech provides deal access. The firm likely leverages his personal brand and co-investor relationships in Hong Kong and the UK.
What investment stages does Palekana typically target?
Palekana appears to target early-stage venture in biotechnology, particularly longevity, as well as real estate investments in Hong Kong. Stage preferences beyond these are not publicly specified.
Which sectors does Palekana explicitly avoid?
No explicit avoidance list is public. The firm's disclosed activities center on biotech, property, and public equities, suggesting a lower interest in heavy industry or energy.
How is Palekana related to Jim Mellon's other entities?
Palekana is Mellon's single-family office, separate from his philanthropic Jim Mellon Foundation. He also has ties to Juvenescence Ltd, a biotech firm he co-founded, which operates independently but may share investment themes.
Does Palekana maintain philanthropic structures, and how are they separated?
Yes, the Jim Mellon Foundation is a charitable entity focusing on medical research and education, legally distinct from Palekana's investment activities.
What is Palekana's known posture on co-investments alongside external GPs?
The firm's involvement in Juvenescence and Hong Kong property suggests a willingness to co-invest with other investors or GPs, but no specific co-investment program is documented.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: